182 related articles for article (PubMed ID: 30385176)
1. A-kinase anchor protein 12 (AKAP12) inhibits cell migration in breast cancer.
Soh RYZ; Lim JP; Samy RP; Chua PJ; Bay BH
Exp Mol Pathol; 2018 Dec; 105(3):364-370. PubMed ID: 30385176
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endothelial cell migration through the down‑regulation of MMP-9 by A-kinase anchoring protein 12.
Lee SW; Jung KH; Jeong CH; Seo JH; Yoon DK; Suh JK; Kim KW; Kim WJ
Mol Med Rep; 2011; 4(1):145-9. PubMed ID: 21461577
[TBL] [Abstract][Full Text] [Related]
3. Re-expression of AKAP12 inhibits progression and metastasis potential of colorectal carcinoma in vivo and in vitro.
Liu W; Guan M; Hu T; Gu X; Lu Y
PLoS One; 2011; 6(8):e24015. PubMed ID: 21918680
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer.
He P; Li K; Li SB; Hu TT; Guan M; Sun FY; Liu WW
Int J Oncol; 2018 Apr; 52(4):1305-1316. PubMed ID: 29484387
[TBL] [Abstract][Full Text] [Related]
5. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway.
Su B; Bu Y; Engelberg D; Gelman IH
J Biol Chem; 2010 Feb; 285(7):4578-86. PubMed ID: 20018890
[TBL] [Abstract][Full Text] [Related]
6. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.
Goeppert B; Schmezer P; Dutruel C; Oakes C; Renner M; Breinig M; Warth A; Vogel MN; Mittelbronn M; Mehrabi A; Gdynia G; Penzel R; Longerich T; Breuhahn K; Popanda O; Plass C; Schirmacher P; Kern MA
Hepatology; 2010 Dec; 52(6):2023-33. PubMed ID: 20979053
[TBL] [Abstract][Full Text] [Related]
8. Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12.
Akakura S; Nochajski P; Gao L; Sotomayor P; Matsui S; Gelman IH
Cell Cycle; 2010 Dec; 9(23):4656-65. PubMed ID: 21099353
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic induction of AKAP12 variant 2 shifts PKA-mediated protein phosphorylation to enhance migration and metastasis of melanoma cells.
Finger EC; Castellini L; Rankin EB; Vilalta M; Krieg AJ; Jiang D; Banh A; Zundel W; Powell MB; Giaccia AJ
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4441-6. PubMed ID: 25792458
[TBL] [Abstract][Full Text] [Related]
10. AKAP12 deficiency impairs VEGF-induced endothelial cell migration and sprouting.
Benz PM; Ding Y; Stingl H; Loot AE; Zink J; Wittig I; Popp R; Fleming I
Acta Physiol (Oxf); 2020 Jan; 228(1):e13325. PubMed ID: 31162891
[TBL] [Abstract][Full Text] [Related]
11. A-kinase anchoring protein 12 regulates the completion of cytokinesis.
Choi MC; Lee YU; Kim SH; Park JH; Kim HA; Oh DY; Im SA; Kim TY; Jong HS; Bang YJ
Biochem Biophys Res Commun; 2008 Aug; 373(1):85-9. PubMed ID: 18554502
[TBL] [Abstract][Full Text] [Related]
12. Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12.
Su B; Gao L; Meng F; Guo LW; Rothschild J; Gelman IH
Oncogene; 2013 Apr; 32(16):2016-26. PubMed ID: 22710722
[TBL] [Abstract][Full Text] [Related]
13. SSeCKS/AKAP12 induces repulsion between human prostate cancer and microvessel endothelial cells through the activation of Semaphorin 3F.
Xie W; Su W; Zhang L; Shang Q; Su B
Biochem Biophys Res Commun; 2017 Sep; 490(4):1394-1398. PubMed ID: 28698137
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-144 inhibits proliferation and promotes the apoptosis of myelodysplastic syndrome cells through the activation of the AKAP12-dependent ERK1/2 signaling pathway.
Qian W; Jin F; Zhao Y; Chen Y; Ge L; Liu L; Yang M
Cell Signal; 2020 Apr; 68():109493. PubMed ID: 31809872
[TBL] [Abstract][Full Text] [Related]
15. Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12.
Gelman IH
Cancer Metastasis Rev; 2012 Dec; 31(3-4):493-500. PubMed ID: 22684366
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
[TBL] [Abstract][Full Text] [Related]
17. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
18. AKAP12 induces apoptotic cell death in human fibrosarcoma cells by regulating CDKI-cyclin D1 and caspase-3 activity.
Yoon DK; Jeong CH; Jun HO; Chun KH; Cha JH; Seo JH; Lee HY; Choi YK; Ahn BJ; Lee SK; Kim KW
Cancer Lett; 2007 Aug; 254(1):111-8. PubMed ID: 17442483
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
[TBL] [Abstract][Full Text] [Related]
20. SSeCKS/Gravin/AKAP12 Inhibits PKCζ-Mediated Reduction of ERK5 Transactivation to Prevent Endotoxin-Induced Vascular dysfunction.
Li Z; Hu J; Guo J; Fan L; Wang S; Dou N; Zuo J; Yu S
Cardiovasc Toxicol; 2019 Aug; 19(4):372-381. PubMed ID: 30805771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
